Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K152428
    Date Cleared
    2016-03-31

    (218 days)

    Product Code
    Regulation Number
    878.4460
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SensiCare PI surgeon's glove is a disposable device made of synthetic rubber intended to be worn by operating room personnel to protect a surgical wound from contamination. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The SensiCare PI Surgical Gloves are disposable powder-free surgical gloves that are intended to be worn by surgeons and/or operating room personnel to protect a surgical wound from contamination. The gloves are made with polyisoprene and are cream in color. The SensiCare PI Surgical Gloves are available in a smooth grip and are constructed with a beaded cuff. The gloves have been tested for use with chemotherapy drugs per ASTM D6978.

    AI/ML Overview

    This document is a 510(k) Premarket Notification for the SensiCare PI Surgical Gloves. It outlines the device's characteristics, intended use, and a comparison to a predicate device. The primary performance testing described relates to the glove's resistance to chemotherapy drugs and its physical properties.

    Here's an analysis of the acceptance criteria and study information provided:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria for the SensiCare PI Surgical Gloves are based on compliance with specific ASTM (American Society for Testing and Materials) and ISO (International Organization for Standardization) standards, as well as FDA regulations.

    Acceptance Criteria CategoryStandard / ReferenceAcceptance CriterionReported Device Performance
    Chemotherapy Drug Permeation (Breakthrough Detection Time)ASTM D6978Not explicitly stated as a minimum "acceptance criteria" but rather as a performance benchmark compared to the predicate and intended use guidance (e.g., minimum breakthrough time of less than 30 minutes for certain drugs). The relevant criteria would be meeting or exceeding the performance of the predicate device.Carmustine (BCNU) 3.3 mg/ml (3,300 ppm): 10.1 min. (10.1, 10.1, 10.1)Cisplatin 1.0 mg/ml (1,000 ppm): 240 min.Cyclophosphamide (Cytoxan) 20 mg/ml (20,000 ppm): 240 min.Cytarabine 100 mg/ml (100,000 ppm): 240 min.Dacarbazine (DTIC) 10.0 mg/ml (10,000 ppm): 240 min.Doxorubicin Hydrochloride 2.0 mg/ml (2,000 ppm): 240 min.Etoposide (Toposar) 20.0 mg/ml (20,000 ppm): 240 min.Fluorouracil 50.0 mg/ml (50,000 ppm): 240 min.Ifosfamide 50.0 mg/ml (50,000 ppm): 240 min.Methotrexate 25 mg/ml (25,000 ppm): 240 min.Mitomycin C 0.5 mg/ml (500 ppm): 240 min.Mitoxantrone 2.0 mg/ml (2,000 ppm): 240 min.Paclitaxel (Taxol) 6.0 mg/ml (6,000 ppm): 240 min.Thiotepa 10.0 mg/ml (10,000 ppm): 11.6 min. (20.2, 21.5, 11.6)Vincristine Sulfate 1.0 mg/ml (1,000 ppm): 240 min.(Note: Carmustine and Thiotepa had breakthrough times less than 30 minutes, necessitating a warning in the intended use statement.)
    Dimensions - LengthASTM D3577270mm min.Meets ASTM D 3577 (270mm min.)
    Dimensions - WidthASTM D35775 ½ - 70±6mm, 6 - 76±6mm, 6 ½ - 83±6mm, 7 - 89±6mm, 7 ½ - 95±6mm, 8 - 102±6mm, 8 ½ - 108±6mm, 9 - 114±6mmMeets ASTM D 3577
    Dimensions – Finger ThicknessASTM D35770.10mm min.Meets ASTM D3577 (0.10mm min.)
    Dimensions – Palm ThicknessASTM D35770.10mm min.Meets ASTM D3577 (0.10mm min.)
    Dimension – Cuff ThicknessASTM D35770.10mm min.Meets ASTM D3577 (0.10mm min.)
    Physical Properties (Before Aging) - Tensile StrengthASTM D357717 MPa min.Meets ASTM D3577 (17 MPa min.)
    Physical Properties (Before Aging) - Ultimate ElongationASTM D3577650% min.Meets ASTM D3577 (650% min.)
    Physical Properties (Before Aging) - Stress at 500% ElongationASTM D35777.0 MPa min.Meets ASTM D3577 (7.0 MPa min.)
    Physical Properties (After Aging) - Tensile StrengthASTM D357712 MPa min.Meets ASTM D3577 (12 MPa min.)
    Physical Properties (After Aging) - Ultimate ElongationASTM D3577490% min.Meets ASTM D3577 (490% min.)
    Freedom from Holes21 CFR 800.20 & ASTM D3577 (tested per ASTM D5151)Inspection Level 1, AQL 1.5Meets 21 CFR 800.20 and ASTM D3577 when tested in accordance with ASTM D5151 (Inspection Level 1, AQL 1.5)
    Residual PowderASTM D3577<2mg of residual powder<2mg of residual powder when tested in accordance with ASTM D3577
    Biocompatibility - Primary Skin IrritationISO 10993-10Device is not an irritant (Under the conditions of the study)Under the conditions of the study (per ISO 10993-10), the device is not an irritant
    Biocompatibility - SensitizationISO 10993-10Device is not a sensitizer (Under the conditions of the study)Under the conditions of the study (per ISO 10993-10), the device is not a sensitizer
    Sterility Assurance Level (SAL)ISO 1113710-6Gamma 10-6 (This implies the SAL was met; the method used was gamma irradiation to achieve this level)

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size for Test Set: The document does not explicitly state the exact "sample size" in terms of number of gloves tested for each individual performance test (e.g., how many gloves for tensile strength, how many for permeation). Instead, it references adherence to specific ASTM and ISO standards, which inherently include their own sampling plans and acceptance criteria. For example, ASTM D5151 for freedom from holes specifies "Inspection Level 1, AQL 1.5," which dictates the sample size based on the lot size.
    • Data Provenance: The document does not specify the country of origin for the data or whether the studies were retrospective or prospective. Given the nature of medical device testing for regulatory submission, these are typically prospective, controlled bench tests conducted in a laboratory setting.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This information is not applicable to this type of device. The ground truth for surgical gloves, especially regarding physical properties and chemotherapy permeation, is established through objective, standardized laboratory testing against established physical and chemical metrics defined in national and international standards (ASTM, ISO). It does not involve expert consensus on subjective interpretations like image analysis or clinical outcomes.

    4. Adjudication Method for the Test Set

    This information is not applicable to this type of device. Adjudication methods (like 2+1, 3+1) are typically used in studies where human expert review is involved to establish a "ground truth" (e.g., in medical image analysis). For physical device testing, the results are objectively measured from the device directly.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not applicable to this device. An MRMC study is relevant for diagnostic devices, particularly those involving human interpretation of data (e.g., radiologists interpreting images, often with AI assistance). This device is a surgical glove, which is a physical barrier device, and does not involve "human readers" or "AI assistance" in its direct function for diagnosis or interpretation.

    6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done

    This information is not applicable to this device, as it is a physical device and does not involve algorithms or AI.

    7. The Type of Ground Truth Used

    The ground truth used for this device is based on objective, quantitative measurements compliant with standardized test methods. These include:

    • Standardized Physical Properties: Measurements of dimensions (length, width, thickness), tensile strength, and ultimate elongation as defined by ASTM D3577.
    • Permeation Resistance: Measurement of breakthrough detection time for chemotherapy drugs as defined by ASTM D6978-05.
    • Freedom from Holes: Determined by water leak tests according to ASTM D5151, with acceptance based on AQL (Acceptable Quality Level) specified in 21 CFR 800.20 and ASTM D3577.
    • Biocompatibility: Results from validated in vitro or in vivo tests (like primary skin irritation and sensitization) as per ISO 10993-10 standards.

    8. The Sample Size for the Training Set

    This information is not applicable to this device. "Training set" refers to data used to train machine learning models. This device is a physical product and does not involve AI/ML models. Development and manufacturing of surgical gloves rely on engineering specifications and materials science, not data training.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable to this device for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1